Nikita K Dave, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Headshot of Nikita K Dave, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

My education and training

  • Residency: Hospital of the University of Pennsylvania

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Dave is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Dave, N.K., Carvajal, V., Carter, J.S., Cook, M., Thomas, C., Schuster, S.J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., Nasta, S.D. Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma , International Conference of Malignant Lymphoma/Lugano, Swizterland.: 2025


Dave, N.K., Carvajal, V., Carter, J.S., Cook, M., Thomas, C., Schuster, S.J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., Nasta, S.D. Chimeric Antigen Receptor T-Cell Therapy in the Management of Secondary Central Nervous System Lymphomas , Cellicon Valley Meeting, Philadelphia, PA.: 2025


Dave, N.K., Carvajal, P., Watts, A.C., Carter, J.S., Cook, M., Thomas, C., Tsai, D.E., Schuster, S.J., Gerson, J.N., Barta, S.K., Svoboda, J., Chong, E.A., Hwang, W., Landsburg, D.J., Nasta, S.D. Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia , 2(3): 2025,100102.


Ward, R., Dave, N.K., Pai, L.L., Colbourn, R., Banihashemi, A., Nasta, S.D., Babatunde, V. Methotrexate-associated Peripheral Neuropathy on 18 F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis , Clin Nucl Med , 51(2): 2025,e144-e146.


Dave N.K. A Case of Primary CNS Lymphoma Complicated by a Puzzling Peripheral Neuropathy. , Philadelphia Lymphoma Research Foundation Rounds/Philadelphia, PA.: 2025


Dave, N.K., Carvajal, V., Carter, J., Tsai, D.E., Schuster, S.J., Gerson, J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., & Nasta, S.D. Outcomes in Primary CNS Lymphoma: A Single Institution Experience from the Abramson Cancer Center , American Society of Hematology Conference/San Diego, California.: 2024


Brooks, T. R., Zabor, E. C., Bedelu, Y. B., Dave, N., Landsburg, D. J., Nedved, A. N., Wang, Y., Reinert, C., Major, A., Sears-Smith, M., Ghosh, N., Salafian, K., Ayers, E., Miller, J., Grover, N., Peterson, C., Khan, C., Bliven, S. P., Narkhede, M. S., … Hill, B. T. Real-world outcomes with Bispecific T-cell engagers (REALBiTE) for relapsed or refractory large B-cell lymphoma: A multi-center, retrospective cohort study , American Society of Hematology Conference, San Diego, California.: 2024


Dave, N.K., Morrissette, J.J., Schuster, S.J., Nasta, S.D., Gerson, J.N., Barta, S.K., Svoboda, J., Chong, E.A., Lim, M.S., Landsburg, D.J. Clinical Laboratory mutation Analysis Performed on Tumor Biopsies from patients with First Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Curative-Intent Immunochemotherapy , American Society of Hematology Conference/New Orleans, Louisiana, USA.: 2022


Dave N.K. Response to Neoadjuvant Treatment for Esophageal Cancer May Predict Increased Incidence of Brain Metastases Compared to Other Metastasis Sites , Memorial Sloan Kettering Cancer Center/New York City, NY.: 2017